Loss of Dystrophin and β-Sarcoglycan Significantly Exacerbates the Phenotype of Laminin α2 Chain–Deficient Animals
- 1 March 2014
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 184 (3) , 740-752
Abstract
No abstract availableKeywords
Funding Information
- Muscular Dystrophy Association
- Association Française contre les Myopathies
- Crafoord Foundation
- Kock Foundation
- Alfred Österlund Foundation
- the Swedish Research Council
This publication has 62 references indexed in Scilit:
- Sparing of extraocular muscle in aging and muscular dystrophies: A myogenic precursor cell hypothesisExperimental Cell Research, 2011
- Transgenic Expression of Laminin α1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular DystrophyThe American Journal of Pathology, 2011
- A Dystroglycan Mutation Associated with Limb-Girdle Muscular DystrophyNew England Journal of Medicine, 2011
- Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategiesSkeletal Muscle, 2011
- Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain DeficiencyPLOS ONE, 2010
- Dystroglycan versatility in cell adhesion: a tale of multiple motifsCell Communication and Signaling, 2010
- Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycanProceedings of the National Academy of Sciences, 2009
- Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx miceHuman Molecular Genetics, 2009
- An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophyNature, 2001
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992